EMA reiterates positive recommendation for Eisai-Biogen’s Alzheimer’s drug Reuters Mar 3, 2025 The EMA's human medicines committee last year backed Leqembi for a narrower set of patients than those evaluated in a late-stage…
Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says… EP News Bureau Jul 26, 2024 Leqembi is the only approved treatment in China that has shown efficacy in slowing the progression of Alzheimer’s by directly…
Alzheimer’s drug Leqembi launched by Eisai, Biogen in China EP News Bureau Jun 28, 2024 China is the third country to launch LEQEMBI following the US and Japan
USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM… EP News Bureau Mar 6, 2023 USFDA accepts Eisai's sBLA and grants priority review for approval of LEQEMBITM Alzheimer's treatment